PAREXEL International Corp (NASDAQ:PRXL)

Delayed Data
As of Jul 02
 +0.01 / +0.02%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

PAREXEL International Corp. is a biopharmaceutical services company, which provides clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries. It operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics. The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affiairs, patient recruitment and investigator site services. The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting. The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes. The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Contact Information

PAREXEL International Corp.
195 West Street
Waltham Massachusetts 02451
P:(781) 487-9900
Investor Relations:
(781) 434-4118



Mutual fund holders62.17%
Other institutional41.69%
Individual stakeholders2.82%

Top Executives

Josef H. von RickenbachChairman & Chief Executive Officer
Mark A. GoldbergPresident & Chief Operating Officer
Ingo BankChief Financial Officer & Senior Vice President
Peter SteigerChief Scientific Officer & Vice President
Sy PretoriusChief Scientific Officer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account